Login | New Member? Signup Free
ChangeDetect » News

ACLU, PUBPAT Seek to Challenge Patentability of Isolated Genes Before Supreme Court

The American Civil Liberties Union and the Public Patent Foundation have decided to ask the Supreme Court to take up their case challenging Myriad Genetics’ patents on the BRCA 1 and BRCA 2 genes.

Tags: , , , , , , , , , ,

Parties in Myriad BRCA Patent Suit Ask Appeals Court for Rehearing

NEW YORK Plaintiffs and defendants in a suit seeking to overturn Myriad Genetics’ BRCA patents have filed separate briefs with the US Court of Appeals for the Federal Circuit seeking a rehearing of the case.

Tags: , , , , , , , , ,

Appeals Court Decides Isolated Dna Patentable, Myriad’s Analytical Method Claims Not

While ruling that isolated gene sequences are not products of nature and are therefore patentable, the Court of Appeals for the Federal Circuit today decided that Myriad Genetics’ method claims for “comparing” and “analyzing” gene sequences did not meet the criteria for patent eligibility. (6 hours ago)

Tags: , , , , ,

Myriad, Aclu Case Hits Higher Court

NEW YORK A US federal circuit court heard oral arguments yesterday from Myriad Genetics, the American Civil Liberties Union, and the Department of Justice in a case about gene patenting that could have a wide impact on the genomics and molecular diagnostics business and research fields. (4 hours ago)

Tags: , , , , , , , , ,

Goldman Analyst Says Myriad’s Stock Buyback Strategy Suggests Slowing Organic Growth

During hard economic times, what does a diagnostic company do when it is unable to grow shareholder value through increased test sales and the introduction of new products? One strategy, as recently exercised by Myriad Genetics, is to repurchase a portion of its stocks. (52 mins ago)

Tags: , , , , , , ,